Genetic findings of Cypriot spinal muscular atrophy patients

L. Theodorou, P. Nicolaou, P. Koutsou, A. Georghiou, V. Anastasiadou, G. Tanteles, T. Kyriakides, E. Zamba-Papanicolaou, K. Christodoulou

Research output: Contribution to journalArticlepeer-review


Spinal muscular atrophy (SMA) is an autosomal recessive, neurodegenerative disorder characterised commonly by proximal muscle weakness and wasting in the absence of sensory signs. Deletion or disruption of the SMN1 gene causes the disease. The SMN1 gene is located within an inverted duplication on chromosome 5q13 with the genes SMN2, NAIP and GTF2H2. MLPA analysis of 13 Cypriot SMA patients revealed that, 12 patients carried a homozygous SMN1 gene deletion and one patient carried two copies of the SMN1 gene. Two of 13 cases were a consequence of a paternally originating de novo mutation. Five genotypes were identified within the population, with the most frequent being a homozygous SMN1 and NAIP genes deletion. In conclusion, genotype–phenotype correlation revealed that SMN2 is inversely related to disease severity and that NAIP and GTF2H2 act as negative modifiers. This study provided, for the first time, a comprehensive overview of gene copy numbers and inheritance patterns within Cypriot SMA families.

Original languageEnglish
Pages (from-to)1829-1834
Number of pages6
JournalNeurological Sciences
Issue number10
Publication statusPublished - 30 Oct 2015


  • De novo mutation
  • Genotype–phenotype analysis
  • GTF2H2
  • NAIP
  • SMA
  • SMN1


Dive into the research topics of 'Genetic findings of Cypriot spinal muscular atrophy patients'. Together they form a unique fingerprint.

Cite this